B. Berkey
Cancer Research · 2002–2008
A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from B. Berkey's perspective
Ordered by how strongly the researchers B. Berkey trusts endorse each paper. Same corpus, a different order for every researcher.
- Nonparametric Estimation from Incomplete Observations
- The Statistical Analysis of Failure Time Data (Technometrics)
- On the Criterion that a Given System of Deviations from the Probable in the Case of a Correlated System of Variables is Such that it Can be Reasonably Supposed to have Arisen from Random Sampling
- Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data (The Lancet)
- Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. (Journal of Clinical Oncology)
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (Nature)
- Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. (Cancer Cell)
- Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. (Cancer Cell)
- Regulation of lung injury and repair by Toll-like receptors and hyaluronan (Nature Medicine)
- Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. (New England Journal of Medicine)
Their papers
- A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. (2008) — 1,007 citations
- Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. (2006) — 698 citations
- Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. (2002) — 1,217 citations